Entries by


Dr. Randy Schatzman On Dodging Disruption: The New Fundraising Norm Business of Biotech Podcast

Press Release

Bolt Biotherapeutics Presents BDC-1001 Ongoing Clinical Trial Design and Supportive Preclinical Data at Society for Immunotherapy of Cancer Annual Meeting


CMC Considerations For In-Human Studies with Drs. Edith Perez and Nathan Ihle Business of Biotech Podcast

Media Coverage

U.S. Patent for Bolt Biotherapeutics’ Boltbody™ ISAC Platform Technology is a Major Milestone in the Development of BDC-1001 ADC Review